Literature DB >> 9858836

The genomic breakpoint and chimeric transcripts in the EWSR1-ETV4/E1AF gene fusion in Ewing sarcoma.

S Ishida1, K Yoshida, Y Kaneko, Y Tanaka, Y Sasaki, F Urano, A Umezawa, J Hata, K Fujinaga.   

Abstract

Chromosome translocation creates a fusion between the EWSR1 gene and an ETS family gene. The fusion between these two genes is a characteristic feature of Ewing sarcoma. We previously identified a fourth translocation, t(17;22)(q12;q12), in genomic DNA isolated from cells of patients affected with Ewing sarcoma. The discovery of this translocation suggested that there might be a novel EWSR1-ETV4 fusion gene. In the present study, we determined the genomic breakpoint and characterized the chimeric transcript of the EWSR1-ETV4 fusion gene in two t(17;22) Ewing sarcomas. Reverse transcriptase-PCR assay showed an in-frame fusion between the 5'-terminal region of EWSR1 and the 3' end of ETV4 (alias E1AF, PEA3); the chimeric transcript could thus serve as a template for expression of a protein composed of the N-terminal portion of EWSR1 fused to the DNA-binding domain of ETV4. Long PCR and sequence analysis of genomic DNA revealed that either exon 8 or intron 7 of EWSR1 is fused to the same intron of ETV4 in both tumors. Several palindromic oligomer sequences were found close to the breakpoints in both genes. The 159-bp Alu-like sequence was repeated in the breakpoint region of the ETV4 gene. These observations suggest a mechanism of EWSR1-ETV4 gene fusion.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9858836     DOI: 10.1159/000015119

Source DB:  PubMed          Journal:  Cytogenet Cell Genet        ISSN: 0301-0171


  10 in total

1.  A method for accurate detection of translocation junctions in Ewing family of tumors.

Authors:  T Morishita; M E Bolander; K Zhang; S Tamai; Y Mii; G Sarkar
Journal:  Mol Biotechnol       Date:  2001-06       Impact factor: 2.695

Review 2.  Targeted therapies for advanced Ewing sarcoma family of tumors.

Authors:  Yunyun Jiang; Joseph Ludwig; Filip Janku
Journal:  Cancer Treat Rev       Date:  2015-03-27       Impact factor: 12.111

Review 3.  Ewing sarcoma and Ewing-like tumors.

Authors:  Marta Sbaraglia; Alberto Righi; Marco Gambarotti; Angelo P Dei Tos
Journal:  Virchows Arch       Date:  2019-12-04       Impact factor: 4.064

4.  Saccharomyces cerevisiae as a model system to define the chromosomal instability phenotype.

Authors:  Christopher D Putnam; Vincent Pennaneach; Richard D Kolodner
Journal:  Mol Cell Biol       Date:  2005-08       Impact factor: 4.272

5.  Increased ETV4 expression correlates with estrogen-enhanced proliferation and invasiveness of cholangiocarcinoma cells.

Authors:  Ekapot Singsuksawat; Chanitra Thuwajit; Komgrid Charngkaew; Peti Thuwajit
Journal:  Cancer Cell Int       Date:  2018-02-20       Impact factor: 5.722

6.  Molecular analysis of Ewing's sarcoma: another fusion gene, EWS-E1AF, available for diagnosis.

Authors:  F Urano; A Umezawa; H Yabe; W Hong; K Yoshida; K Fujinaga; J Hata
Journal:  Jpn J Cancer Res       Date:  1998-07

7.  Survey of Paediatric Oncologists and Pathologists regarding Their Views and Experiences with Variant Translocations in Ewing and Ewing-Like Sarcoma: A Report of the Children's Oncology Group.

Authors:  Michael D Kinnaman; Chong Zhu; Daniel A Weiser; Sana Mohiuddin; Pooja Hingorani; Michael Roth; Jonathan Gill; Katherine A Janeway; Richard Gorlick; Stephen L Lessnick; Patrick J Grohar
Journal:  Sarcoma       Date:  2020-12-05

Review 8.  Molecular detection and targeting of EWSR1 fusion transcripts in soft tissue tumors.

Authors:  Monica Cantile; Laura Marra; Renato Franco; Paolo Ascierto; Giuseppina Liguori; Annarosaria De Chiara; Gerardo Botti
Journal:  Med Oncol       Date:  2013-01-18       Impact factor: 3.064

9.  Oncopig Soft-Tissue Sarcomas Recapitulate Key Transcriptional Features of Human Sarcomas.

Authors:  Kyle M Schachtschneider; Yingkai Liu; Suvi Mäkeläinen; Ole Madsen; Laurie A Rund; Martien A M Groenen; Lawrence B Schook
Journal:  Sci Rep       Date:  2017-06-01       Impact factor: 4.379

Review 10.  Breakthrough Technologies Reshape the Ewing Sarcoma Molecular Landscape.

Authors:  Carmen Salguero-Aranda; Ana Teresa Amaral; Joaquín Olmedo-Pelayo; Juan Diaz-Martin; Enrique de Álava
Journal:  Cells       Date:  2020-03-26       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.